(Q37965588)

26 August 2017

title

Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia (English)

1 reference

26 August 2017

0 references

1 reference

5

1 reference

26 August 2017

Wai Ping Lee

1

1 reference

26 August 2017

Borunendra N Datta

series ordinal

2

1 reference

26 August 2017

Beng Beng Ong

series ordinal

3

1 reference

26 August 2017

Alan Rees

series ordinal

4

1 reference

26 August 2017

publication date

1 December 2011

1 reference

American journal of cardiovascular drugs

26 August 2017

published in

1 reference

26 August 2017

volume

11

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

363-370

1 reference

Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Diagnosing familial hypercholesterolaemia: the relevance of genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Plasma exchange in the management of homozygous familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

A new approach to the management of familial hypercholesterolaemia: Removal of plasma-cholesterol based on the principle of affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Recommendations for the use of LDL apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Lipidfiltration--safe and effective methodology to perform lipid-apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

A systematic review of LDL apheresis in the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Efficacy criteria and cholesterol targets for LDL apheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

21 January 2018

Lipoprotein apheresis

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Retrospective analysis of long-term lipid apheresis at a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Therapeutic apheresis: results from a single center in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Long-term effects of LDL apheresis in patients with severe hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11594970-000000000-00000

10.2165/11594970-000000000-00000

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1034151667

0 references

1 reference